top of page


IOTA ADNEX Model: Revolutionizing Risk Assessment in Ovarian Cancer Screening
Ovarian cancer remains one of the most challenging gynecological cancers to detect early. Its symptoms often mimic less serious conditions, leading to delayed diagnosis and treatment. Accurate risk assessment tools are essential for improving early detection and guiding clinical decisions. The IOTA ADNEX model has emerged as a powerful method to assess the risk of ovarian cancer in women presenting with adnexal masses. This blog post explores how the ADNEX model works, its be
Dr. Reena Sherene
4 days ago5 min read


Exploring the Role of Tsirulnikovs Triple Ligation in PPH Management
Postpartum hemorrhage (PPH) remains one of the leading causes of maternal mortality worldwide. Managing severe bleeding after childbirth requires timely and effective interventions to save lives and preserve fertility. Among the surgical techniques developed to control PPH, Tsirulnikovs triple ligation stands out as a valuable option. This procedure targets the uterine blood supply to reduce bleeding while maintaining uterine integrity. This article explores the role of Tsiru
Dr. Reena Sherene
4 days ago4 min read


Understanding the MEOWS Score in Obstetrics and Its Importance for Maternal Care
Maternal health remains a critical focus in healthcare worldwide. Early detection of complications during pregnancy and childbirth can save lives. One tool that has gained attention for improving maternal outcomes is the MEOWS score. This scoring system helps healthcare providers identify early signs of deterioration in pregnant or postpartum women. Understanding how MEOWS works and why it matters can empower medical teams and improve care for mothers. MEOWS score monitoring
Dr. Reena Sherene
4 days ago3 min read
ABNORMAL UTERINE BLEEDING MANAGEMENT- FOGSI
AUB MANAGEMENT IN PERIMENOPAUSE - FOGSI The medical management of Abnormal Uterine Bleeding (AUB) according to FOGSI (Federation of Obstetric and Gynaecological Societies of India) guidelines is categorized into managing acute heavy episodes vs. long-term treatment. Treatment is tailored based on patient age, fertility desires, and underlying causes (using the PALM-COEIN classification). 1. Acute Heavy AUB (Immediate Control) For active, heavy bleeding, the goal is to stabil
Dr. Reena Sherene
4 days ago2 min read


MUSA CRITERIA- DIAGNOSIS OF ADENOMYOSIS BY ULTRASOUND
MUSA DIAGNOSTIC CRITERIA asymmetrical thickening (a), cysts (b), hyperechoic islands (c), fan-shaped shadowing (d), echogenic subendometrial lines and buds (e), translesional vascularity (f), irregular junctional zone (g) and interrupted junctional zone (h). The MUSA (Morphological Uterus Sonographic Assessment) criteria provide a standardized system for describing and reporting ultrasound features of the uterine myometrium, primarily used to diagnose adenomyosis. The criter
Dr. Reena Sherene
4 days ago2 min read
SCD: SICKLE CELL DISEASE IN PREGNANCY -BRITISH SOCIETY OF HEMATOLOGY RECOMMENDATIONS
SCD: SICKLE CELL DISEASE IN PREGNANCY -BRITISH SOCIETY OF HEMATOLOGY RECOMMENDATIONS (updating previous RCOG GTG) SCD Complications Hemolytic Anaemia Vaso occlusion Acute painful crisis Acute chest syndrome Pulmonary hypertension Stroke Renal dysfunction Retinal disease Leg ulcer Cholelithiasis A vascular necrosis Hip complications in pregnancy HbSS HbSC- increased risks Preconception care Genetic screening Annual review from child Partner testing High risk couples d
Dr. Reena Sherene
6 days ago6 min read
'JADA' PPH DEVICE- PPH MANAGEMENT
What is “JADA System” : PPH management:
Dr. Reena Sherene
Jun 23 min read


ACOG 2026 UPDATES: PMB Evaluation
ACOG 2026 UPDATES: PMB Evaluation:
Dr. Reena Sherene
Jun 22 min read


WHO+FIGO+ICM Updates on PPH guidelines:
WHO+FIGO+ICM Updates on PPH guidelines:
Dr. Reena Sherene
Jun 22 min read


ASRM 2026 Recommends 2 Tests in “ALL PATIENTS “ of RPL:
ASRM 2026 Recommends 2 Tests in “ALL PATIENTS” of RPL:
Dr. Reena Sherene
Jun 23 min read


NHM GUIDELINES: INDUCTION OF LABOR
NHM GUIDELINES: INDUCTION OF LABOR
Dr. Reena Sherene
Jun 23 min read


FOGSI GUIDELINES: INDUCTION OF LABOR
FOGSI GUIDELINES: INDUCTION OF LABOR
Dr. Reena Sherene
Jun 24 min read


SURVIVING SEPSIS CAMPAIGN :”1-HOUR RESUSCITATION BUNDLE”:
SURVIVING SEPSIS CAMPAIGN :”1-HOUR RESUSCITATION BUNDLE”: is the gold standard for managing sepsis and septic shock. Treatment must begin immediately upon suspecting sepsis.
Dr. Reena Sherene
Jun 21 min read


ACOG 2026 UPDATES: CERVICAL CANCER SCREENING
ACOG 2026 Updates on Cervical Cancer
Dr. Reena Sherene
Jun 22 min read


ISUOG GUIDELINES: ANEUPLOIDY SCREENING IN TWINS
ISUOG GUIDELINES: ANEUPLOIDY SCREENING IN TWINS
Dr. Reena Sherene
Jun 22 min read


FOGSI 2026 update: “IV Nicardipine”
FOGSI 2026 update: “IV Nicardipine”
Dr. Reena Sherene
Jun 21 min read


LOW DOSE ASPIRIN: FOGSI 2026 Updates:
LOW DOSE ASPIRIN: FOGSI 2026 Updates:
Dr. Reena Sherene
Jun 22 min read


FOGSI 2026- GESTOSIS SCORE
Score 1: Age 35 years Age 19 years Maternal anemia Obesity (BMI >30) Primigravida Short duration of sperm exposure (cohabitation) Woman born as small for gestational age Family history of cardiovascular disease Polycystic ovary syndrome Inter pregnancy interval more than 7 years Conceived with Assisted Reproductive (IVF/ICSI) Treatment MAP >85 mm of Hg Chronic vascular disease(Dyslipidemia) Excessive weight gain during pregnancy
Dr. Reena Sherene
Jun 22 min read


FOGSI DEFINITIONS - HYPERTENSIVE DISORDERS IN PREGNANCY
3.1 Gestational Hypertension Gestational hypertension is defined as a blood pressure ≥140/90 mmHg detected on two occasions at least 4 hours apart, occurring after 20 weeks of gestation, usually returning to normal within 6weeks postpartum, in the absence of other features of preeclampsia. 3.2 Preeclampsia Preeclampsia is a hypertensive disorder characterized by a blood pressure ≥140/90 mmHg detected on two occasions at least 4 hours apart, occurring aft er 20 weeks of gestat
Dr. Reena Sherene
Jun 22 min read
bottom of page